A Senate vote failed to halt the WISeR AI-based prior authorization pilot for traditional Medicare claims.
Key Details
- 1Senate Democrats attempted to use the Congressional Review Act to stop the CMS WISeR program but lost 46-50.
- 2WISeR uses AI to automate the approval and denial of traditional Medicare claims in six states.
- 3The pilot involves multiple private vendors: Cohere Health, Genzeon Corporation, Humata Health, Innovaccer, Virtix Health, and Zyter.
- 4Opponents cite risks of care delays and denials for seniors due to AI-driven prior authorizations.
- 5Supporters argue the pilot could reduce waste and fraud in Medicare.
Why It Matters
AI-driven prior authorization has major implications for radiology reimbursement, patient access, and care delays. This marks a pivotal test of AI’s regulatory and economic impact on healthcare workflows, particularly for imaging services.
Source
HealthExec
Related News
•HealthExec
AI Reimbursement, Biomedical Research, and Exec Survey Highlight Healthcare Trends
Healthcare AI adoption is rising, but ROI measurement and clinical impact remain key challenges.
•HealthExec
Mayo Clinic Sued Over Alleged AI Improprieties and Whistleblower Retaliation
A former Mayo Clinic research director sues the institution, alleging retaliation after raising concerns about improper AI use affecting patient safety and data integrity.
•Radiology Business
Use of Generative AI in Radiology Manuscripts Surges, Raising Integrity Concerns
Disclosure of generative AI usage in radiology manuscript writing has more than doubled in recent years, prompting editorial caution about scientific integrity.